- Active Fund Investments
Fund Investments - Active
Please navigate through the following funds. By clicking on each of their logos, you will be directed to a description of the fund and a link to their website.
Accel Partners is widely regarded as one of the leading venture capital investors in the United States. Accel Partners has offices in Palo Alto, California, Princeton, New Jersey, and London, England. Accel Partners’ European office leverages Accel’s collective experience, knowledge and network. Senior members of the US- based investment team are closely involved in the deployment of Accel Partners Europe, and this, coupled with Accel’s strong corporate relationships and US presence, is of great benefit to the European fund. Notable private investments made by prior Accel funds include: ArrowPoint Communications, Avici Systems, Foundry Networks, UUNET.
Accel Partners Europe is an investment in the Montagu Newhall Global Partners I portfolio, Accel IX and Accel – London II are an investment in the Montagu Newhall Global Partners II portfolio and Accel X is an investment in the Montagu Newhall Global Partners III portfolio.
ACCEL PARTNERS AND IDG VENTURE CAPITAL have combined forces to form Accel- IDG China Growth Fund. Based in Palo Alto, California, Accel Partners has been investing in early-stage venture capital since its inception in 1984. Accel manages over $3 billion in capital commitments and its investment focus is in early stage information technology and communications companies. IDG Venture Capital, based in Beijing, was founded in 1992 by International Data Group (IDG), a leading worldwide provider of information technology services. IDG Venture capital was one of the earliest American venture companies to enter the China market and has invested over $200 million in one hundred portfolio companies in China. Accel - IDG China Growth Fund seeks to actively invest in early stage and growth stage Chinese companies within the technology, media, and consumer sectors.
Accel- IDG China Growth Fund is an investment in the Montagu Newhall Global Partners II portfolio and Accel-IDG China Growth Fund II is an investment in the Montagu Newhall Global Partners III portfolio. IDG-Accel China Capital is an investment in the Montagu Newhall Global Partners IV portfolio.
ALTA PARTNERS is a venture capital firm founded in 1996 in San Francisco, California. Alta Partners has funded approximately 130 life sciences and information technology companies to date. Historically, the firm invested in both early and later stage companies, through separate stage-specific funds. Alta Partners is a successor to Burr, Egan, Deleage & Co., which was founded in 1979.
Alta Partners focuses on investments in life sciences companies with significant growth prospects and exceptional capital appreciation potential. Alta currently manages seven venture funds aggregating approximately $1.5 billion in committed capital. These funds fall into two families: the Alta California Partners (ACP) funds, which originally focused on early-stage opportunities in both life sciences and information technology, and today, invest solely in early-stage life sciences, and the Alta BioPharma Partners (ABP) funds, which focus on later-stage life sciences opportunities. Notable private investments made by prior Alta Partners funds include: Dynavax Technologies, Onyx Pharmaceuticals, and Connetics Corporation.
Alta Partners VIII is an investment in the Montagu Newhall Global Partners
III portfolio.
www.altapartners.com
BRIDGESCALE PARTNERS, which was founded in 2005, is a venture capital firm located in Menlo Park, CA. Bridgescale Partners invests in U.S. based later-stage technology companies. The general partners have more than 20 years of venture capital experience at leading early and later-stage institutions, and bring deep expertise in helping semiconductor, communication, and internet companies scale their businesses. Bridgescale targets companies which are at a stage where they need expansion capital to "scale" their business and "bridge" them to an IPO or sale.
Bridgescale Partners I is an investment in the Montagu Newhall Global Partners II portfolio.
CLARUS VENTURES, which was founded in 2005, is venture capital firm with offices in Cambridge, MA and South San Francisco, CA. Clarus invests in early stage biopharmaceutical products, as well as later stage medical devices in the United States and Europe. The six founding partners of Clarus all came from MPM Capital, each possessing over twenty years of operating and venture experience. The fund will aim to make 17-20 investments ranging from $20-$30 million per deal.
Clarus Lifesciences I is an investment in the Montagu Newhall Global Partners II portfolio and Clarus Lifesciences II is an investment in the Montagu Newhall Global Partners III portfolio.
Delphi Ventures which was founded in 1988, is a venture capital firm located in Menlo Park, CA. Over its seventeen-year history, Delphi Ventures has been able to establish a reputation as one of the most experienced and respected healthcare venture capital firms in the industry. Delphi Ventures has over 50 years of cumulative venture capital experience between team members that include five partners. Supplementing the venture capital background is over 30 years of cumulative operating experience and 20 years of investment banking experience. Delphi has focused historically on early stage healthcare investing, including medical device, biotechnology, and healthcare services companies. Delphi has invested in over 150 companies across the healthcare sector. More than 50 of these companies have completed initial public offerings or have been acquired by leading healthcare corporations. Notable Delphi companies include: Applied Molecular Evolution, Interventional Technologies, Oratec, TheraSense and Synaptics.
Delphi Ventures VII is an investment in the Montagu Newhall Global Partners II portfolio and Delphi Ventures VIII is an investment in the Montagu Newhall Global Partners IV portfolio.
DOLL CAPITAL MANAGEMENT (DCM) is an early stage venture
capital firm founded in 1996 and practices in the U.S., China and Japan.
DCM has $1.6 billion under management across five funds that focus their
investments on communications, digital media, software and semiconductors.
The DCM team has extensive experience operating IT companies, and many
have been co-founders of start-up companies. The majority of DCM’s
team also has working experience in Asia. This experience has been a major
contributing factors to DCM’s deal flow. Notable private investments
made by prior DCM funds include: 51job, About.com, Foundry Networks and
UUnet.
DCM V, L.P. is an investment in the Montagu Newhall Global Partners III
portfolio.
www.dcmvc.com
Domain Associates is an early stage venture capital firm with offices in Princeton, New Jersey and Laguna Niguel, California. Domain, founded in 1985, focuses its investment activity in the life sciences sector, investing in three main sectors: biopharmaceuticals, medical devices, and eHealth initiatives. Domain's investment strategy has remained broadly unchanged over its 21-year history. Domain's very experienced management team includes career venture capitalists, as well as former executives with large pharmaceutical companies and venture-backed start-ups. Notable private investments made by prior Domain Partner funds include: US Bioscience, Connetics Corporation, Dura Pharmaceuticals and Sepracor.
Domain Partners V is an investment in the Montagu Newhall Global Partners I portfolio, Domain Partners VI is an investment in the Montagu Newhall Global Partners II portfolio, Domain Public Equity Partners is an investment in Montagu Newhall Global Partners II, and Domain Partners VII is an investment in the Montagu Newhall Global Partners III portfolio.
FAIRHAVEN CAPITAL PARTNERS, based in Cambridge, Massachusetts, is a venture capital firm investing in early stage, high potential companies with rapid growth characteristics. The founders of the Fairhaven venture firm previously managed TD Capital Ventures, which is the venture capital arm of TD Capital Group. The Managing Directors employ a disciplined thesis based approach to investing in both the US and Canada.
Fairhaven Capital Partners is an investment in the Montagu Newhall Global Partners IV portfolio.
FOUNDERS FUND, based in San Francisco, CA., is a venture capital fund focused on early stage investments in high growth Internet and Internet related technology, digital media, and social networking companies located in and around the San Francisco Bay Area. The Partners are recognized experts in the Fund’s target fields, having founded some of the most successful internet technology companies of the past decade, including: PayPal, Napster, Plaxo, Palantir, and Facebook.
The Founders Fund II is an investment in the Montagu Newhall Global Partners III portfolio.
FOUNDRY GROUP, based in Boulder, CO., is an early-stage venture capital fund focused on making investments in the information technology sector. The Principals are experienced investors and entrepreneurs and have worked together since 2001 at Mobius Venture Capital, Inc. The Principals combined have greater than 65 years of investing, operating and technology experience and have founded or been the first institutional investor in over 50 companies. Typically, the companies in which the Foundry Group will initially invest will be early-stage or seed-stage and usually will be the first institutional investor in the company.
Foundry Venture Capital 2007 is an investment in the Montagu Newhall Global Partners III portfolio.
Frazier Healthcare Ventures was founded in 1991 as one of the first dedicated healthcare venture funds. Frazier Healthcare is a recognized leader in the healthcare industry, with more than $750 million under management in four funds. With offices in Seattle, Washington and Palo Alto, California, Frazier Healthcare has built a franchise among entrepreneurs and fellow venture capitalists which has led to the development of a strong network within the industry. Frazier has built a strong syndicate of co-investment partners, including Abingworth, InterWest, New Enterprise Associates and Venrock.
Frazier Healthcare’s current investment strategy is one that has evolved from investing experience through multiple funds and market cycles. Frazier Healthcare V has implemented a balanced investment strategy which focuses on biopharmaceuticals, medical devices and healthcare services. Notable private investments made by prior Frazier Healthcare Ventures funds include: Rigel, Corixa, CompHealth Group andTularik.
Frazier Healthcare V is an investment in the Montagu Newhall Global Partners II portfolio and Frazier Healthcare VI is an investment in the Montagu Newhall Global Partners III portfolio.
HealthCare Ventures (HCV) was founded in 1985. They are headquartered in Princeton, New Jersey and have offices in Cambridge, Massachusetts. HCV has six General Partners, three in Princeton and three in Cambridge. Three of the six have been General Partners at HCV for more than 10 years.
HealthCare Ventures focuses on venture capital investments in the biotechnology, biopharmaceutical and life science sectors. The majority of investments are in companies based in the Northeast, Mid-Atlantic and California regions. HCV will make an initial investment of $500,000 to $20,000,000 in the form of equity or debt convertible to equity, and generally they will initially invest in the region of $10 million in a single company. Notable private investments made by prior HealthCare Ventures funds include: Millennium, HGS and MedImmune, Inc.
HCV VII is an investment in the Montagu Newhall Global Partners I portfolio, and HCV VIII is an investment in Montagu Newhall Global Partners II.
INFOTECH PACIFIC VENTURES, was founded in 2000 through
the initiative and support of the MII to provide early-stage China-based
technology start-ups with much needed venture capital and to manage the
Ministry of Information Industry’s (MII) IT Grant Program. Infotech
has a deep and long-standing relationship with the MII, a unique position
in the Chinese venture capital community. Infotech has historically been
the sole manager of the MII’s venture investments and the MII’s
IT Grant Program. Managing the MII’s IT Grant Program provides Infotech
with access to thousands of high-quality early-stage Chinese start-ups
per year. The Firm also has significant relationships with many of the
leading technology companies in China, including China Electronics Corp.,
China Putian, and Hi-Sense. These relationships provide Infotech with
a unique perspective into a wide range of commercial, regulatory and developmental
matters and key insights into every stage of the venture capital process
in China.
Infotech Pacific Ventures is an investment in the Montagu Newhall Global
Partners III portfolio.
www.infovc.com
Insight Venture Partners (“Insight”) is one of the leading institutional investors in growth-stage software, software-enabled services, and the Internet. Since inception in 1995, Insight has invested over $900 million and raised over $1.1 billion in four funds. With Insight Venture Partners V, L.P. (“Insight V”) the firm continues to implement the same strategy that has made it successful to date. With an office in New York City, the Insight investment team consists of 30 professionals. Notable companies Insight has invested in include Exchange Applications, Illuminet, I-Many, Quest Software and Greenfield Online.
Insight V is an investment in the Montagu Newhall Global Partners II portfolio and Insight VI is an investment in the Montagu Newhall Global Partners III portfolio.
LIGHTSPEED PARTNERS was founded in 1994 and is based in Menlo Park, California. Lightspeed Venture Partners is an early-stage technology venture firm focused on helping entrepreneurs build large sustainable companies globally. The partners of Lightspeed have invested over $800M in more than 100 technology companies over the past two decades. Lightspeed Partners invest in the U.S., Israel, and Asia and have contributed strong operational and sector expertise to market leaders such as Blue Nile, Brocade, Ciena, eHealthinsurance, Galileo Technology, Informatica, and Kiva Software, working closely with these companies throughout the early stages of their business development lifecycles.
Lightspeed Ventures VII is an investment in the Montagu Newhall Global Partners II portfolio and Lightspeed Ventures VIII is an investment in the Montagu Newhall Global Partners IV portfolio.
M/C VENTURE PARTNERS, which was founded in 1986, is a venture capital firm located in Boston, Massachusetts. M/C Venture Partners specializes in the early identification of the most promising segments in emerging communications, IT, and media in hope of generating top quartile performance for its investors. The firm believes that the following three attributes are the keys to its past and future success as well as differentiating itself from their competition: the disciplined industry focus, proactive investing approach, and the analytical risk/return focused investing style. Notable private investments made by prior M/C Venture Partners funds include: Telecorp Holding Corporation, Brooks Fiber Properties, and Trumper Communications.
M/C Venture Partners VI is an investment in the Montagu Newhall Global Partners II Portfolio and Montagu Newhall Global Partners III Portfolio.
MOHR DAVIDOW VENTURES (MDV) is a leading early stage venture capital firm based in Menlo Park, CA. that for nearly 25 years has identified mentored and developed entrepreneurs and young companies redefining business, technology and medicine. The firm invests around three major business and science concerns: Driving the Digital World; Powering the Planet; and Personalizing Medicine. The firm partners with entrepreneurs who have deep expertise in technology, energy and materials, and life sciences. MDV's team engages very early in the life of a company to impact its long-term success.
MDV IX is an investment in the Montagu Newhall Global Partners III portfolio
MORGENTHALER VENTURE PARTNERS, based in Menlo Park, California and also maintains offices in Boston, Massachusetts, Princeton, New Jersey, Cleveland Ohio, and Boulder, Colorado, has managed over $2.5 billion in leveraged buyout and venture capital limited partner commitments, helped build more than 250 early-stage information technology and life science companies and has been involved with more than 100 companies that have either gone public or been successfully sold. Morgenthaler Venture Partners is focused on early-stage venture capital opportunities in information technology and life sciences.
Morgenthaler Venture Partners IX is an investment in the Montagu Newhall Global Partners IV portfolio.
www.morgenthaler.com/ventures/default.asp
New Enterprise Associates (NEA) founded in 1978, focuses its investment activity in the information technology, medical and life sciences sectors. NEA has offices in Baltimore, Maryland, Reston, Virginia, and Menlo Park, California. NEA, whose investment strategy has remained broadly unchanged since the formation of its first fund, has an excellent long-term track record.
As with previous funds, the majority of investments in NEA 10 and NEA 11 are expected to be in companies in the seed and start up stages of development. NEA continues to develop its venture growth equity strategy and also invests opportunistically in expansion and mezzanine financings. Notable private investments made by prior New Enterprise Associates funds include: Juniper Networks, UUNET, 3COM and Novacea, Inc.
NEA 10 is an investment in the Montagu Newhall Global Partners I portfolio, NEA 11 is an investment in the Montagu Newhall Global Partners II portfolio and NEA 12 is an investment of Montagu Newhall Global Partners II and in Montagu Newhall Global Partners III.
NEXUS INDIA CAPITAL, which was founded in 2006 and has offices in Mumbai, India and Menlo Park, California, is focused on early to growth-stage companies based in India across all sectors. The Nexus Principal Advisors offer a unique combination of operational, investment and management leadership that can help drive the development of leading enterprises in India. They have been successful founders and CEOs of companies in India and the US. They have first hand experience of launching and scaling businesses, and can provide hands-on support to the portfolio companies.
Their first fund, Nexus India Capital I, which is $150 million in size, will make investments in companies targeting either global or the high-growth India market. Investment sectors for Nexus are expected to include software, technology-enabled consumer and business services, media, communications, devices as well as other emerging opportunities.
Nexus India Capital I is an investment in the Montagu Newhall Global Partners III portfolio and Nexus India Capital II is an investment in the Montagu Newhall Global Partners IV portfolio.
North Bridge Venture Partners, which
was founded in 1986 in Boston, is focused on investing in early stage
companies on the East Coast of the United States. The investment professionals
at North Bridge have considerable venture capital and operating experience.
North Bridge has developed a very strong track record on each of its
previous funds.
North Bridge focuses on three main sectors - Internet, communications,
and software. Consistent with previous funds, North Bridge indicates
that most of its new fund will be invested in early-stage companies. Notable
private investments made by prior North Bridge Venture Partners funds
include: Centra, SilverStream, SolidWorks and Sycamore Networks.
North Bridge V is an investment in the Montagu Newhall Global Partners I portfolio, North Bridge VI is an investment in the Montagu Newhall Global Partners II portfolio and North Bridge Growth Equity I is an investment in the Montagu Newhall Global Partners III portfolio.
Oak Investment Partners, which was
founded in 1978, has offices in Westport, Connecticut, Palo Alto, California,
and Minneapolis, Minnesota. Oak's investment professionals have many
years of venture capital and operating experience, and its investment
track record has been consistently very strong. Oak focuses on investments
in companies that help to scale the Internet or expand the services
it provides. This includes communication equipment and services, enterprise
and consumer services, and Internet infrastructure. Notable private
investments made by prior Oak Investment Partners funds include: Compaq,
Inktomi, Seagate and Vitesse Semiconductor Corporation.
Oak Investment Partners X is an investment in the Montagu Newhall Global Partners I portfolio, Oak Investment Partners XI is an investment in the Montagu Newhall Global Partners II portfolio, and Oak Investment Partners XII is an investment of Montagu Newhall Global Partners III.
OPENVIEW VENTURE PARTNERS is a late stage venture capital
firm based in Boston, Massachusetts, who has raised their first fund.
OpenView Venture Partners is a spin off of Insight Venture Partners led
by former partner, Scott Maxwell, specializing in small growth equity
investment. OpenView seeks to invest in high growth companies that are
at or near profitability who have yet to take institutional capital.
OpenView Venture Partners, L.P. is an investment in the Montagu Newhall Global Partners III portfolio.
Polaris Venture Partners has offices
in Boston, Massachusetts, Seattle, Washington, and Austin, Texas. Founded
in 1996 and with over $2 billion under management, Polaris was formed
following the break up of the private equity manager, Burr Egan. In a
relatively short period of time, Polaris has become a highly respected
venture capital firm and its investment team brings a strong mix of skills
to their organization.
Approximately two-thirds of Polaris’s investments are expected to be in the information technology area and one third in the medical area. The information technology portfolio is diversified in a number of markets, including software tools and applications, Internet infrastructure, and data communications/ telecommunications products. The medical portfolio is similarly diversified among markets including medical devices, genomics, drug delivery, and services. Notable private investments made by prior Polaris Venture Partners funds include: Akamai, Allaire, Centra, and Paradigm Genetics.
PVP IV is an investment in the Montagu Newhall Global Partners I portfolio, and PVP V is an investment in the Montagu Newhall Global Partners II.
PROQUEST INVESTMENTS (“Proquest”), founded in 1998 with offices in Princeton, NJ, San Diego, CA, and Montreal, Canada, is a healthcare dedicated venture capital firm with over $900 million under management in four funds. ProQuest’s core strategy is to build companies with clearly differentiated products or potential products that address significant unmet medical needs. ProQuest was one of the first healthcare venture funds to make private investment in public equities (PIPEs). ProQuest was also one of the first U.S. based funds to open an office in Canada. The firm has monitored the Canadian market since inception as it represents a rich source of high quality deal flow, often under-recognized by other investors.
ProQuest Investments IV is an investment in the Montagu Newhall Global
Partners III portfolio.
http://www.proquestvc.com
Questmark Partners, which was founded in 1998, is based in Baltimore, Maryland. Questmark's investment professionals have many years of venture capital and investing experience. A number of the Questmark investment professionals spent the majority of their professional careers with Alex Brown, a provider of investment banking services to emerging growth companies in software, communications, health care and consumer services and products industries.
Questmark looks to achieve superior long-term capital growth principally through equity or equity-linked investments in private companies that are expected to IPO or to be sold within two years after investment by the fund. Questmark targets best-of-breed companies in industry sectors that the fund knows best (primarily internet, software, communications technology and products, health care, and consumer services and products businesses) and will look for strong market acceptance for a company's products or services before investing. Notable private investments made by prior Questmark Partners, L.P. funds include: Aspect Medical Systems, Invisalign and SpeechWorks.
Questmark Partners II is an investment in the Montagu Newhall Global Partners I portfolio and Questmark Partners III is an investment in the Montagu Newhall Global Partners III portfolio
SCALE VENTURE PARTNERS, based in Foster City, CA, employs
a thesis-based strategy to identify innovative development-stage technology
and healthcare investments in emerging markets. The Scale team collectively
offers decades of technology and venture industry experience to development-stage
companies in hardware, software, healthcare and medical devices. The seven
member general partner team has invested in over $500 million across 52
companies since its formation in 2000.
Scale Ventures II is an investment in the Montagu Newhall Global Partners III portfolio.
http://www.baventurepartners.com
SIERRA VENTURES is a private venture capital firm focusing its investments in communications, software and internet related companies. Sierra’s current investments include companies based in the United States, Canada, China and India. Sierra Ventures manages eight venture capital partnerships, which together have more than $1.1 billion of committed capital. As the firm approaches its 24th year, Sierra has been able to form a wide network of individuals and organizations with whom it has shared considerable past success. This network provides a strong source of deal flow and an extensive network of individuals available to help portfolio companies achieve success. Notable private investments made by prior Sierra funds include: Amerigroup, Advanced Technology Materials, FatBrain.com, Intuit, and MicroMuse.
Sierra Ventures IX is an investment in the Montagu Newhall Global Partners II portfolio.
SIGMA PARTNERS was founded in 1984 and has offices in
Boston, MA., Menlo Park, CA., and San Ramon, CA. With over $1.5 billion
under management, the Sigma funds have invested in more than 195 private
companies and focus on early-stage information technology companies in
the United States. Sigma’s managers bring to the Partnership extensive
and diverse backgrounds and represent over 85 years of combined venture
investing experience. Drawing on deep operational backgrounds as entrepreneurs
and executives, Sigma's partners provide management teams with practical
strategic counsel through every phase of company growth.
Sigma Partners 8 is an investment in the Montagu Newhall Global Partners
III portfolio.
www.sigmapartners.com
SOFTBANK VENUTRE CAPITAL CHINA (SBCVC), based in Shanghai, China, is a venture capital firm founded in 2000 focused on investments in early, expansion, and late stage companies in the information technology, healthcare, consumer, clean technology, and retail sectors. SBCVC currently manages three venture funds aggregating over $500 million in committed capital.
SBCVC III is currently an investment in the Montagu Newhall Global Partners III and Montagu Newhall Global Partners IV portfolios.
Split Rock Partners focuses on early stage investments in healthcare, software and internet services. The firm, which has offices in Minneapolis and Menlo Park, was formed in June 2004 by the healthcare and software investment teams of St. Paul Venture Capital. The Split Rock team continues to manage St. Paul Venture Capital's existing healthcare and software portfolio. In healthcare, Split Rock specializes in medical device and specialty pharmaceutical opportunities. In software and services, the firm focuses on enterprise software and business and consumer services that leverage the internet.
The firm's primary geographic focus is on companies based in the Upper Midwest and West Coast. The managing directors and co-founders of Split Rock are Michael Gorman, Jim Simons, Dave Stassen, and Allan Will. Representative companies backed by Split Rock's team include Adaytum Software, Disc Dynamics, Dexcom, Emphasys Medical, LowerMyBills.com, QuinStreet and Xtent Medical.
Split Rock Partners I is an investment in the Montagu Newhall Global Partners II portfolio and Split Rock Partners II is an investment in the Montagu Newhall Global Partners IV portfolio.
SUMMERHILL VENTURE PARTNERS is a venture capital firm managing approximately $250 million of capital. Founded in 1987, with offices in Toronto, Ottawa and Boston, Summerhill Venture Partners has built a track record of investing in and developing some of North America’s most successful emerging growth companies in the areas of communications, digital media and information technology.
Summerhill Ventures I is an investment in the Montagu Newhall Global Partners III portfolio.
Summit Partners, which was founded in 1984, has offices in Boston, Massachusetts, Palo Alto, California, and London, England. Summit Partners focuses on growth-stage investments ranging from $10 - $250 million in various sectors. These sectors include: software, communications technology and services, semiconductors and electronics, information services, business services, financial services, healthcare and life sciences, industrial products, and consumer products.
Since inception, Summit Partners has raised in excess of $5.5 billion in capital and invested in more than 255 businesses. These companies have completed more than 105 public offerings and more than 90 strategic sales or mergers.
Summit Ventures VII is an investment in the Montagu Newhall Global Partners II portfolio.
TA Associates was founded in 1968 and
is one of the largest and most experienced growth capital firms in the
private capital industry. With offices in Boston, Massachusetts, Menlo
Park, California, and London, England, TA invests in private companies
that are rapidly growing and is usually the first “institutional”
money in the company. TA has over $5 billion in capital commitments and
has invested in over 350 companies during its history. TA has an industry-diversified
approach but has deep expertise in technology, financial and business
services, healthcare and consumer industries.
Notable private investments made by prior TA Associates funds include: Ameritrade Holding Corporation, AND1, Invitrogen, bSQUARE.
TA Atlantic & Pacific V and TA X are investments in the Montagu Newhall Global Partners II portfolio, and TA Atlantic & Pacific VI is an investment in the Montagu Newhall Global Partners III portfolio.
THIRD ROCK VENTURES, based in Boston, MA., is a first-time venture firm started by four former Millennium Pharmaceutical executives and closed at $350 million for their first fund, Third Rock Ventures, L.P. The Fund aims to build highly valued new product and platform companies by leveraging the rapid incorporation of novel and convergent technologies revolutionizing experimental therapeutics. The team hopes to leverage their biotech and pharmaceutical experience in order to cost efficiently build value.
Third Rock Ventures is an investment in the Montagu Newhall Global Partners III portfolio.
Venrock Associates was established in 1969 and has offices in Menlo Park, California, New York, New York and Cambridge Massachusetts. Venrock was founded as the venture capital arm of the Rockefeller Family and today continues a six-decade tradition of funding entrepreneurs and establishing successful, enduring companies.
Venrock's activities have focused on early stage companies in information technology and healthcare, with investments in such companies as Intel, Apple Computer, Stratacom, Check Point Software, Visual Networks, and DoubleClick in the IT sector, and Millennium Pharmaceuticals, Genetics Institute, Oratec Interventions, and Caliper Technologies in the healthcare sector. Venrock is almost always the lead investor and an active participant in the growth of the company. Venrock’s proven track record has placed them among the leaders in the venture industry. Notable private investments made by prior Venrock funds include: Intel, Apple and Dallas Semiconductor.
Venrock Associates IV is an investment in the Montagu Newhall Global Partners I portfolio and in the Montagu Newhall Global Partners II portfolio and Venrock Associates V is an investment in the Montagu Newhall Global Partners III portfolio.
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |